NCT06247800 Virtual Reality: Distraction During Small Bore Intercostal Chest Drain Insertion
| NCT ID | NCT06247800 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National University of Malaysia |
| Condition | Pleural Effusion |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2026-12-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-02-01 with a primary completion date of 2026-12-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Intercostal chest drain (ICC) insertion is a common procedure done worldwide to treat and diagnose pleural disease. It is used to evacuate fluid, blood, or air in the cavity from a myriad of causes namely pleural effusions of different etiologies, empyema, hemothorax, chylothorax and pneumothorax. It also functions as a route for antibiotics, pleurodesis and fibrinolytics. Hippocrates, whose practiced medicine 2,400 years ago, is often credited with being the first to insert a metal tube into the pleural region to drain fluid. It wasn't until the 19th century that a closed drainage system was properly documented in the literature, although open drainage remained to be the norm for quite some time. In the past, large-bore tubes (24-32 F) were recommended in nearly all circumstances and were inserted using a blunt dissection technique. However, during the past two decades, small-bore catheters have become increasingly popular. They were first used to drain abdominal collections and have now been adopted for use in draining the pleural cavity utilizing the needle and guide wire Seldinger procedure, typically with radiological guidance. In addition to that, Seldinger technique allow us to insert the catheter at lower intercostals spaces without injury to the diaphragm or abdominal organs, thereby ensuring patient safety.
Eligibility Criteria
Inclusion Criteria: * All participants undergoing ICC insertion * Participants who could understand and give consent Exclusion Criteria * Participants who are unable to understand or give consent * Ventilated patients * Participants who are not comfortable wearing VR device * Participants who are unable to communicate (illiterate, had hearing impairment, mute, blind or had memory impairment) * Participants with craniofacial deformity * Participants who are on sedative medication Traumatic or post Motor Vehicular Accident patient Participants undergoing Indwelling pleural catheter insertion Participants with anxiety disorder Exclusion Criteria: \-
Contact & Investigator
Mohamed Faisal Abdul Hamid, MBBS (IIUM)
PRINCIPAL INVESTIGATOR
National University of Malaysia
Frequently Asked Questions
Who can join the NCT06247800 clinical trial?
This trial is open to participants of all sexes, studying Pleural Effusion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06247800 currently recruiting?
Yes, NCT06247800 is actively recruiting participants. Contact the research team at faisal.hamid@ppukm.ukm.edu.my for enrollment information.
Where is the NCT06247800 trial being conducted?
This trial is being conducted at Kuala Lumpur, Malaysia.
Who is sponsoring the NCT06247800 clinical trial?
NCT06247800 is sponsored by National University of Malaysia. The principal investigator is Mohamed Faisal Abdul Hamid, MBBS (IIUM) at National University of Malaysia. The trial plans to enroll 80 participants.